Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin Add-On to NSAIDs in Lumbar Spinal Stenosis Peripheral Neuropathic Pain
jRCTs021200007Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mirogabalin in lumbar spinal stenosis (LSS) and Peripheral neuropathic pain (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Change in Visual Analogue Scale (VAS) for lower limb pain at 12 weeks. Started Jun 2020; status: completed.
02
Drugs
mirogabalin
03
Conditions
lumbar spinal stenosis (LSS)Peripheral neuropathic pain
Beyond the preview
Go deeper on jRCTs021200007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021200007.